This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Company News for Dec 3, 2020
by Zacks Equity Research
Companies In The News Are: NTAP, WKHS, AMD, PDCO
Patterson Companies (PDCO) Q2 Earnings Top Estimates, Up Y/Y
by Zacks Equity Research
Patterson Companies' (PDCO) fiscal second-quarter 2021 results benefit from strong segmental performance.
Patterson Cos. (PDCO) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Patterson Cos. (PDCO) delivered earnings and revenue surprises of 65.79% and 8.81%, respectively, for the quarter ended October 2020. Do the numbers hold clues to what lies ahead for the stock?
PDCO vs. MMSI: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
PDCO vs. MMSI: Which Stock Is the Better Value Option?
Is Patterson Companies (PDCO) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (PDCO) Outperforming Other Medical Stocks This Year?
Analysts Estimate Patterson Cos. (PDCO) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Patterson Cos. (PDCO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What's in Store for Patterson Companies' (PDCO) Q2 Earnings?
by Zacks Equity Research
Patterson Companies' (PDCO) fiscal second-quarter results are likely to reflect improvement at Dental segment.
NextGen (NXGN) Strengthens Portfolio of NextGen Solutions
by Zacks Equity Research
NextGen (NXGN) continues to boost its robust portfolio of NextGen solutions with the latest adoption of NextGen Enterprise by OSMC.
Here's Why You Should Invest in Cardinal Health (CAH) Stock
by Zacks Equity Research
Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment, diversified product portfolio and strategic buyouts.
LHC Group (LHCG) Forays into Oklahoma With New Hospice Buyout
by Zacks Equity Research
LHC Group (LHCG) buys Grace Hospice of Oklahoma to expand its hospice service to Tulsa and throughout the nation.
Here's Why You Should Retain Stryker (SYK) Stock Right Now
by Zacks Equity Research
Stryker (SYK) continues to benefit from strength in its robotic-arm assisted surgery platform - Mako and broad product portfolio. However, pricing pressure raises concern.
PerkinElmer's Non-Invasive Saliva-Based Testing Gets CE Mark
by Zacks Equity Research
PerkinElmer's (PKI) new saliva-based collection and asymptomatic test solution receives CE-IVD mark.
Here's Why You Should Retain McKesson (MCK) Stock for Now
by Zacks Equity Research
McKesson (MCK) continues to benefit from multi-year strategic growth initiative and Distribution Solutions segment.
PDCO vs. COO: Which Stock Is the Better Value Option?
by Zacks Equity Research
PDCO vs. COO: Which Stock Is the Better Value Option?
Has Patterson Companies (PDCO) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (PDCO) Outperforming Other Medical Stocks This Year?
3 Dental Supplies Stocks Set to Shine on the Industry's Upturn
by Trina Mukherjee
Despite the challenges thrown by the COVID-19 pandemic, teledentistry coupled with AI & Robotics should lend support to the Zacks Medical - Dental Supplies industry. CAH, WST and MCK are well positioned to gain from the prospects.
Patterson Cos. (PDCO) Down 7.4% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Patterson Cos. (PDCO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Patterson Cos. (PDCO) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Patterson Cos. (PDCO) delivered earnings and revenue surprises of 50.00% and 4.75%, respectively, for the quarter ended July 2020. Do the numbers hold clues to what lies ahead for the stock?
Patterson Companies (PDCO) Q1 Earnings Top Estimates, Up Y/Y
by Zacks Equity Research
Despite weak performance across Patterson Companies' (PDCO) Dental and Animal Health segments in the fiscal first quarter results, it benefited from aggressive cost savings measures.
Ciena (CIEN) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Ciena's (CIEN) fiscal third-quarter performance is likely to have benefited from the proper execution of its strategy that centers on innovation, diversification and global scale.
What's in Store for Patterson Companies' (PDCO) Q1 Earnings?
by Zacks Equity Research
Patterson Companies' (PDCO) fiscal first-quarter results are likely to reflect sluggishness at Dental segment.
Patterson Cos. (PDCO) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Patterson Cos. (PDCO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Medtronic's (MDT) Q1 Earnings Beat Estimates, Margins Fall
by Zacks Equity Research
Barring Respiratory, Gastrointestinal & Renal, Medtronic (MDT) registers dismal performance in all business segments and geographies in Q1.
PDCO vs. CNMD: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
PDCO vs. CNMD: Which Stock Is the Better Value Option?
5 PEG-Driven Value Stocks to Invest in Coronavirus-Hit Market
by Urmimala Biswas
PEG ratio is complicated, considering the limitations in calculating the future earnings growth potential of a stock.